Kim JJ - Search Results

1

The value of improving failures within a cervical cancer screening program: an example from Norway.

Burger EA, Kim JJ. Burger EA, et al. Among authors: kim jj. Int J Cancer. 2014 Oct 15;135(8):1931-9. doi: 10.1002/ijc.28838. Epub 2014 Mar 20. Int J Cancer. 2014. PMID: 24615416 Free PMC article.

2

Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.

Goldie SJ, Kim JJ, Wright TC. Goldie SJ, et al. Among authors: kim jj. Obstet Gynecol. 2004 Apr;103(4):619-31. doi: 10.1097/01.AOG.0000120143.50098.c7. Obstet Gynecol. 2004. PMID: 15051550

3

Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.

Kim JJ, Wright TC, Goldie SJ. Kim JJ, et al. J Natl Cancer Inst. 2005 Jun 15;97(12):888-95. doi: 10.1093/jnci/dji162. J Natl Cancer Inst. 2005. PMID: 15956650

4

Chapter 19: Cost-effectiveness of cervical cancer screening.

Goldie SJ, Kim JJ, Myers E. Goldie SJ, et al. Among authors: kim jj. Vaccine. 2006 Aug 31;24 Suppl 3:S3/164-70. doi: 10.1016/j.vaccine.2006.05.114. Epub 2006 Jun 22. Vaccine. 2006. PMID: 16950004 Review.

5

Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.

Kim JJ, Ortendahl J, Goldie SJ. Kim JJ, et al. Ann Intern Med. 2009 Oct 20;151(8):538-45. doi: 10.7326/0003-4819-151-8-200910200-00007. Ann Intern Med. 2009. PMID: 19841455 Free PMC article.

6

Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.

Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ. Campos NG, et al. Among authors: kim jj. Int J Cancer. 2012 Jun 1;130(11):2672-84. doi: 10.1002/ijc.26269. Epub 2011 Aug 24. Int J Cancer. 2012. PMID: 21717458 Free PMC article.

7

Using HPV prevalence to predict cervical cancer incidence.

Sharma M, Bruni L, Diaz M, Castellsagué X, de Sanjosé S, Bosch FX, Kim JJ. Sharma M, et al. Among authors: kim jj. Int J Cancer. 2013 Apr 15;132(8):1895-900. doi: 10.1002/ijc.27835. Epub 2012 Oct 11. Int J Cancer. 2013. PMID: 22965284

8

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.

Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Robertson M, Castle PE; New Mexico HPV Pap Registry Steering Committee. Wheeler CM, et al. Int J Cancer. 2014 Aug 1;135(3):624-34. doi: 10.1002/ijc.28605. Epub 2014 Apr 15. Int J Cancer. 2014. PMID: 24226935 Free PMC article.

9

Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.

Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Burger EA, et al. Among authors: kim jj. PLoS One. 2014 Mar 20;9(3):e89974. doi: 10.1371/journal.pone.0089974. eCollection 2014. PLoS One. 2014. PMID: 24651645 Free PMC article.

10

Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.

Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Burger EA, et al. Among authors: kim jj. J Infect Dis. 2015 Jan 15;211(2):206-15. doi: 10.1093/infdis/jiu413. Epub 2014 Jul 23. J Infect Dis. 2015. PMID: 25057044 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,456 results

Search Page

Filters